Use of intravenous liposoluble contrast material for the examination of the liver and spleen in lymphoma.
An experimental contrast material has been developed that, after intravenous injection, selectively opacifies the spleen and liver on computed tomography (CT). The contrast material contains iodinated ester of poppy seed oil in an emulsified form. Clinical trials were recently initiated to test the value of this contrast agent in Hodgkin's and non-Hodgkin's lymphomas. We present here two of our initial patients in whom we found lesions in the spleen or liver following the infusion of the experimental contrast material that were not visualized on the precontrast and urographic contrast material enhanced CT scans.
D000328:Adult; D000368:Aged; D002986:Clinical Trials as Topic; D004998:Ethiodized Oil; D005260:Female; D006689:Hodgkin Disease / Q000000981:diagnostic imaging; D006801:Humans; D007275:Injections, Intravenous; D008113:Liver Neoplasms / Q000000981:diagnostic imaging*; D008223:Lymphoma / Q000000981:diagnostic imaging*; D008297:Male; D013160:Splenic Neoplasms / Q000000981:diagnostic imaging*; D014057:Tomography, X-Ray Computed
C039040:ethiodized oil emulsion 13; D004998:Ethiodized Oil